Plasma vascular endothelial growth factor concentration and alveolar nitric oxide as potential predictors of disease progression and mortality in idiopathic pulmonary fibrosis

Kotecha, Jalpa, Shulgina, Ludmila, Sexton, Darren W., Atkins, Christopher P. and Wilson, Andrew M. (2016) Plasma vascular endothelial growth factor concentration and alveolar nitric oxide as potential predictors of disease progression and mortality in idiopathic pulmonary fibrosis. Journal of Clinical Medicine, 5 (9). ISSN 2077-0383

Preview

PDF (Published manuscript) - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Background: Declining lung function signifies disease progression in idiopathic pulmonary fibrosis (IPF). Vascular endothelial growth factor (VEGF) concentration is associated with declining lung function in 6 and 12-month studies. Alveolar nitric oxide concentration (CANO) is increased in patients with IPF, however its significance is unclear. This study investigated whether baseline plasma VEGF concentration and CANO are associated with disease progression or mortality in IPF. Methods: 27 IPF patients were studied (maximum follow-up 65 months). Baseline plasma VEGF concentration, CANO and pulmonary function tests (PFTs) were measured. PFTs were performed the preceding year and subsequent PFTs and data regarding mortality were collected. Disease progression was defined as one of: death, relative decrease of ≥10% in baseline forced vital capacity (FVC) % predicted, or relative decrease of ≥15% in baseline single breath diffusion capacity of carbon monoxide (TLCO-SB) % predicted. Results: Plasma VEGF concentration was not associated with progression-free survival or mortality. There was a trend towards shorter time to disease progression and death with higher CANO. CANO was significantly higher in patients with previous declining versus stable lung function. Conclusion: The role of VEGF in IPF remains uncertain. It may be of value to further investigate CANO in IPF.

Item Type:	Article
Additional Information:	This is an open access article distributed under the Creative Commons Attribution License (CC BY 4.0).
Uncontrolled Keywords:	idiopathic pulmonary fibrosis,vascular endothelial growth factor,alveolar nitric oxide
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Respiratory and Airways Group Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Centres > Population Health Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Related URLs:	http://www.mdpi.com/2077-0383/5/9/80
Depositing User:	Pure Connector
Date Deposited:	13 Oct 2016 12:00
Last Modified:	13 Nov 2023 17:22
URI:	https://ueaeprints.uea.ac.uk/id/eprint/60919
DOI:	10.3390/jcm5090080

Downloads

Actions (login required)

View Item